These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 35120916)

  • 21. Hepatocellular carcinoma and non-alcoholic fatty liver disease.
    Golabi P; Rhea L; Henry L; Younossi ZM
    Hepatol Int; 2019 Nov; 13(6):688-694. PubMed ID: 31701393
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Non-alcoholic fatty liver disease and hepatocellular carcinoma - 2016].
    Pár A; Pár G
    Orv Hetil; 2016 Jun; 157(25):987-94. PubMed ID: 27287838
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A narrative review on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis versus hepatocellular carcinoma: do you mind?
    Toman D; Sengul I; Pelikán A; Sengul D; Vavra P; Ihnat P; Roman J; Kayaalp C
    Rev Assoc Med Bras (1992); 2022; 68(6):871-874. PubMed ID: 35766704
    [No Abstract]   [Full Text] [Related]  

  • 24. Systematic review with meta-analysis: risk of hepatocellular carcinoma in non-alcoholic steatohepatitis without cirrhosis compared to other liver diseases.
    Stine JG; Wentworth BJ; Zimmet A; Rinella ME; Loomba R; Caldwell SH; Argo CK
    Aliment Pharmacol Ther; 2018 Oct; 48(7):696-703. PubMed ID: 30136293
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of nonalcoholic fatty liver disease and liver cancer.
    Schulz PO; Ferreira FG; Nascimento Mde F; Vieira A; Ribeiro MA; David AI; Szutan LA
    World J Gastroenterol; 2015 Jan; 21(3):913-8. PubMed ID: 25624725
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Maternal obesity: A severe risk factor in hepatocarcinogenesis?
    Colnot S; Lechel A
    J Hepatol; 2020 Sep; 73(3):502-504. PubMed ID: 32593683
    [No Abstract]   [Full Text] [Related]  

  • 27. Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention.
    Huang DQ; El-Serag HB; Loomba R
    Nat Rev Gastroenterol Hepatol; 2021 Apr; 18(4):223-238. PubMed ID: 33349658
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cancer Risk in Patients With Biopsy-Confirmed Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study.
    Simon TG; Roelstraete B; Sharma R; Khalili H; Hagström H; Ludvigsson JF
    Hepatology; 2021 Nov; 74(5):2410-2423. PubMed ID: 33811766
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabolic factors affecting hepatocellular carcinoma in steatohepatitis.
    Zarrinpar A; Faltermeier CM; Agopian VG; Naini BV; Harlander-Locke MP; Kaldas FM; Farmer DG; Busuttil RW
    Liver Int; 2019 Mar; 39(3):531-539. PubMed ID: 30427105
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatocellular carcinoma in nonalcoholic fatty liver: role of environmental and genetic factors.
    Dongiovanni P; Romeo S; Valenti L
    World J Gastroenterol; 2014 Sep; 20(36):12945-55. PubMed ID: 25278690
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Non alcoholic steatohepatitis a precursor for hepatocellular carcinoma development.
    Jiang CM; Pu CW; Hou YH; Chen Z; Alanazy M; Hebbard L
    World J Gastroenterol; 2014 Nov; 20(44):16464-73. PubMed ID: 25469014
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Distinctive features of hepatocellular carcinoma in non-alcoholic fatty liver disease.
    Valenti L; Pedica F; Colombo M
    Dig Liver Dis; 2022 Feb; 54(2):154-163. PubMed ID: 34294580
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nonalcoholic fatty liver disease and hepatocellular carcinoma.
    Kikuchi L; Oliveira CP; Carrilho FJ
    Biomed Res Int; 2014; 2014():106247. PubMed ID: 24738043
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nonalcoholic fatty liver disease, metabolic risk factors, and hepatocellular carcinoma: an open question.
    Streba LA; Vere CC; Rogoveanu I; Streba CT
    World J Gastroenterol; 2015 Apr; 21(14):4103-10. PubMed ID: 25892859
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Distinctive features of hepatocellular carcinoma in non-alcoholic fatty liver disease.
    Degasperi E; Colombo M
    Lancet Gastroenterol Hepatol; 2016 Oct; 1(2):156-164. PubMed ID: 28404072
    [TBL] [Abstract][Full Text] [Related]  

  • 36. NONALCOHOLIC FATTY LIVER DISEASE (NAFLD), MORE THAN A LIVER DISEASE.
    Parise ER
    Arq Gastroenterol; 2019 Sep; 56(3):243-245. PubMed ID: 31633718
    [No Abstract]   [Full Text] [Related]  

  • 37. Is Hepatocellular Cancer the Same Disease in Alcoholic and Nonalcoholic Fatty Liver Diseases?
    Goossens N; Hoshida Y
    Gastroenterology; 2016 Jun; 150(8):1710-7. PubMed ID: 26784140
    [No Abstract]   [Full Text] [Related]  

  • 38. Polygenic risk score: A promising predictor for hepatocellular carcinoma in the population with non-alcoholic fatty liver disease.
    Long J; Bian J; Zhao H
    J Hepatol; 2021 Jun; 74(6):1493-1494. PubMed ID: 33476746
    [No Abstract]   [Full Text] [Related]  

  • 39. Nonalcoholic Steatohepatitis and Hepatocellular Carcinoma: Brazilian Survey.
    Alves VA; D'Albuquerque LA
    Clinics (Sao Paulo); 2016 Aug; 71(8):423-4. PubMed ID: 27626470
    [No Abstract]   [Full Text] [Related]  

  • 40. Women with Cirrhosis: Prevalence, Natural History, and Management.
    Giard JM; Terrault NA
    Gastroenterol Clin North Am; 2016 Jun; 45(2):345-58. PubMed ID: 27261903
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.